CRISPR-Cas9-mediated reactivation of the uricase pseudogene in human cells prevents acute hyperuricemia

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 01, 2021
Source ID
10.1016/j.omtn.2021.08.002

Entities

People

  • Eric A Gaucher
  • Lais De Lima Balico

Organizations

  • Human Frontier Science Program
  • National Institutes of Health
  • National Science Foundation
  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology